SOAFEE, Inc (SOFE) Fair Value & Analysis
Healthcare · US · Market cap $45.3K
Fair value as of: Jun 26, 2026
From 25 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.2100 to $0.0016 (−99.2%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0002 – $0.0016 · fair‑value band $0.0016 – $0.0017 · the $0.0016 price screens below the $0.0016 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SOAFEE, Inc (SOFE) currently trades at $0.0016, while our model-based Fair Value estimate is $0.0016 — implying the stock looks roughly 0.1% undervalued today. We read business quality at 66/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, SOAFEE, Inc generated revenue of $2.2M at a net margin of -4.9%. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
SOAFEE, Inc. provides artificial intelligence (AI) and information technology (IT) services, and enterprise AI software-as a-service (SaaS) solutions for enterprises. It offers AI driven data as a service system (DaaS); SOAFEE healthcare marketplace; applied AI IT services for the health care/life sciences sector; and applied AI SaaS solutions for optimizing business operations. The company was formerly known as Carepay, Inc. and changed its name to SOAFEE, Inc. in February 2022. SOAFEE, Inc. is based in Atlanta, Georgia.
Revenue & earnings trend
FY2009 – FY2022 · reported fiscal years
SOAFEE, Inc reported revenue of $1.5M in FY2022 versus $2.2M in FY2009, a compound −3.0%/yr. Reported net income was $313K in FY2022.
Is SOFE fairly valued? → Check now
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $172.61 | $104.16 | -40% |
| Pro Medicus Limited PME | A$161.58 | A$33.82 | -79% |
| BrightSpring Health Services, Inc BTSG | $67.20 | $26.39 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $86.03 | $54.47 | -37% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is SOAFEE, Inc (SOFE) undervalued?
What is the fair value of SOFE?
What is the quality score of SOFE?
What is the revenue of SOAFEE, Inc (SOFE)?
What is the net profit margin of SOFE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.